EDGESTREAM PARTNERS, L.P. Halozyme Therapeutics, Inc. Transaction History

EDGESTREAM PARTNERS, L.P. portfolio value:

$2.20M
portfolio value

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 55.73K shares 2.20M $39.54 55.73K